Guide to Evaluating a Stem Cell Clinic

Reviewed by Dr. Ankeet Choxi and Jarred Mait, MD

A patient-education guide to due diligence, safety, and informed decision-making

Stem cell therapy is increasingly discussed as an option in regenerative medicine, particularly for joint pain, musculoskeletal injuries, and degenerative conditions. At the same time, clinics offering stem cell-based treatments can vary widely in medical oversight, transparency, and standards of care.

At STEMS Health Regenerative Medicine, patient education is considered a critical part of responsible care. Whether a patient ultimately chooses to pursue treatment or not, understanding how to evaluate a stem cell clinic helps support informed, realistic decision-making.

This guide provides a clear, patient-focused due-diligence framework. Its purpose is not to promote or discourage treatment, but to help patients ask the right questions, recognize red flags, and understand what responsible regenerative care should include.

Why Evaluating a Stem Cell Clinic Matters

Stem cell therapy is not a single, standardized treatment. It includes a range of approaches involving different cell sources, processing methods, delivery techniques, and regulatory pathways. Many applications are still considered investigational for specific conditions.

Because of this, clinics may differ significantly in:

• Medical oversight and provider credentials
• Use of clinical trials or published research
• Regulatory disclosures and compliance language
• Pricing models and follow-up care standards

These differences directly affect patient safety, expectations, and outcomes. A careful evaluation helps patients distinguish between evidence-informed care and marketing-driven claims.

Start With Medical Oversight and Provider Credentials

A foundational question is who is making the medical decisions.

Stem cell–based care should be overseen by licensed medical providers, typically physicians, who are responsible for:

• Patient evaluation and diagnosis
• Determining whether regenerative therapy is appropriate
• Performing or supervising procedures
• Managing follow-up care and complications

Patients should be able to clearly identify:

• The licensed physician directing care
• That provider’s state medical license
• Their clinical role and scope of practice
• Who performs evaluations versus administrative tasks

Clinics operating primarily as wellness centers or sales organizations, rather than medical practices, may not provide the level of oversight appropriate for biologic therapies.

Who Is Actually Making Clinical Decisions?

Patients should clarify whether treatment recommendations come from:

• A licensed physician, after evaluation
• Or non-clinical staff, following preset protocols

 Red flags include:

• Treatment plans presented before medical evaluation
• “One-size-fits-all” protocols applied to all patients
• Sales consultations that replace physician visits

Medical decisions should be made by clinicians, not by marketing or administrative teams.

Clinical Trial Registration and Research Context

Some stem cell clinics participate in registered clinical trials, while others offer treatments that are informed by research but not part of a trial. These are not the same thing, and clinics should clearly explain the difference.

Clinical trial registration helps ensure transparency, ethical oversight, and defined outcome tracking. However, not all legitimate care occurs within a trial setting.

What matters most is honest disclosure of where a treatment falls on the research-to-practice spectrum.

How to Check Clinical Trial Registration

Patients can ask:

• Is the clinic participating in a registered clinical trial?
• If so, where is it registered (e.g., ClinicalTrials.gov)?
• Does the clinic’s description match the listed trial details?

Registration does not guarantee effectiveness. It indicates that the treatment is being studied under defined conditions.

“Research-Based” vs. “Research-Proven”

These terms are often used interchangeably, but they mean very different things.

• Research-based: informed by scientific studies, often early-stage
• Research-proven: supported by consistent clinical evidence and broader acceptance

Clinics should be willing to explain what level of evidence exists, what is still uncertain, and how that uncertainty is communicated to patients.

Published Data and Evidence Transparency

Responsible clinics acknowledge that not all stem cell applications have extensive published data, particularly for emerging uses.

Patients should understand the difference between:

• Peer-reviewed studies
• Case reports or observational data
• Patient testimonials and anecdotes

Testimonials can reflect individual experiences, but they are not scientific evidence.

What to Look for in Published Stem Cell Research

Patients do not need to be scientists, but they can ask basic questions:

• Was the study peer-reviewed?
• How many patients were included?
• Were outcomes measured objectively?
• Is the condition studied similar to yours?

Clinics should be transparent when published data is limited and avoid overstating conclusions.

Regulatory Status and Legal Disclosures

Many stem cell-based procedures are considered investigational for certain conditions. This does not automatically mean unsafe, but it does mean that effectiveness has not been fully established.

Clinics are responsible for explaining:

• Whether a treatment is FDA-approved, cleared, or investigational
• What that status means for patients
• What is known – and unknown – about risks and benefits

Understanding Investigational Therapy Disclosures

A meaningful disclosure should clearly state:

• The treatment’s regulatory status
• That outcomes cannot be guaranteed
• That research is still evolving

 Caution is warranted if a clinic:

• Claims a treatment is “FDA approved” without specifics
• Uses vague language like “FDA compliant” without explanation
• Minimizes or avoids discussion of regulatory status

The Informed Consent Process

Informed consent is not just a form – it is a process.

Patients should receive enough information to understand:

• What is being offered
• What is known and unknown
• What alternatives exist
• What risks are possible

Consent should be provided before payment, with time to review and ask questions.

What a Meaningful Informed Consent Should Include

A responsible consent process covers:

• Potential risks and side effects
• The investigational nature of treatment, if applicable
• Alternative treatment options
• Expected recovery and follow-up
• A clear statement that results are not guaranteed

Warning Signs of Inadequate Consent

 Red flags include:

• Pressure to sign on the same day
• Oversimplified consent forms
• Language that minimizes uncertainty or risk

Patients should feel informed, not rushed.

Pricing Transparency and Financial Practices

Stem cell therapy pricing can vary widely based on cell source, processing, delivery method, and follow-up care.

Patients should understand:

• What is included in the quoted price
• What may cost extra (imaging, follow-ups, repeat treatments)
• Refund, cancellation, or rescheduling policies

Questions to Ask About Cost

• Does pricing include evaluation and follow-up care?
• Are additional treatments expected or optional?
• Are financing arrangements involved?

 Financial red flags include:

• Guaranteed results tied to payment
• Discounts for immediate commitment
• Requests for payment before medical evaluation

Follow-Up Care and Outcome Monitoring

Follow-up care is a core component of responsible regenerative medicine.

Patients should ask:

• How often will follow-up occur?
• Who should be contacted with concerns?
• How are outcomes and complications tracked?

What Follow-Up Care Should Reasonably Include

• Scheduled post-treatment check-ins
• Monitoring for side effects or complications
• Guidance on activity, rehabilitation, and recovery

Complication Management and Continuity of Care

Clinics should clearly explain:

• How unexpected issues are handled
• Whether licensed providers are available after treatment
• How care is coordinated with other healthcare providers if needed

Evaluating Marketing Claims and Guarantees

Stem cell therapy involves biologic variability, which means outcomes cannot be guaranteed.

 Be cautious of clinics that:

• Use words like “cure” or “permanent fix”
• Apply the same claims to unrelated conditions
• Present testimonials as proof

Clear, educational language is a sign of transparency. Absolute claims are not.

A Practical Due-Diligence Checklist for Patients

Before choosing a stem cell clinic, consider whether it provides:

• Licensed medical oversight
• Clear explanation of cell source and handling
• Honest discussion of evidence and uncertainty
• Regulatory and investigational disclosures
• Meaningful informed consent
• Transparent pricing
• Defined follow-up care plans

Making an Informed, Evidence-Based Decision

Stem cell therapy should be approached as a medical process, not a consumer product. The details – evaluation, sourcing, handling, delivery, and follow-up – matter.

For readers of the STEMS Health Regenerative Medicine blog, the goal of this guide is to support thoughtful, informed conversations with licensed providers and to encourage decision-making grounded in evidence, transparency, and individual suitability.

Disclaimer

The information provided in this article is for educational and informational purposes only and is not intended as medical advice. Treatments and outcomes described may not be appropriate for every individual. Always consult a licensed healthcare provider to determine the best course of care for your specific needs.

Certain regenerative medicine procedures discussed – such as stem cell therapy, exosome therapy, or other biologic treatments – may be considered investigational or not FDA-approved for all conditions. Florida law requires that we disclose this status. While these procedures are offered in accordance with state and federal guidelines, their safety and efficacy have not been fully established by the U.S. Food and Drug Administration.

Results vary, and no guarantee of specific outcome or benefit is implied. All medical procedures involve potential risks, which should be discussed with your treating provider prior to treatment.

© STEMS Health Regenerative Medicine, Miami Beach, Florida. All rights reserved.

What are the most important things to look for when evaluating a stem cell clinic?

Patients should prioritize licensed medical oversight, transparency, and accountability. Key factors include whether a licensed physician is directing care, how clearly the clinic explains cell sourcing and handling, whether regulatory status is disclosed, and what follow-up care is provided. Clinics should be willing to discuss evidence limitations, risks, and alternatives—not just potential benefits.

Does participation in a clinical trial mean a stem cell treatment is proven to work?

No. Clinical trial registration does not guarantee effectiveness. It indicates that a treatment is being studied under defined conditions with ethical oversight and outcome tracking. Patients should understand whether a clinic is offering care as part of a registered trial or providing treatment informed by research but outside a trial setting, and what level of evidence currently exists for their specific condition.

Why is informed consent and follow-up care so important in stem cell therapy?

Stem cell therapy often involves investigational or evolving treatments, which makes informed consent essential. Patients should clearly understand what is known, what is uncertain, and what risks may exist before agreeing to treatment. Follow-up care is equally important to monitor outcomes, manage side effects, and address complications if they arise. Responsible clinics view consent and follow-up as ongoing processes, not one-time steps.